Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Fuji
Covington
Fish and Richardson
Cipla
QuintilesIMS

Generated: June 16, 2019

DrugPatentWatch Database Preview

Litigation Details for Cadence Pharmaceuticals, Inc. v. Fresenius Kabi USA, LLC (N.D. Ill. 2013)

« Back to Dashboard

Cadence Pharmaceuticals, Inc. v. Fresenius Kabi USA, LLC (N.D. Ill. 2013)

Docket ➤ Try a Free Trial Date Filed 2013-01-18
Court District Court, N.D. Illinois Date Terminated 2013-03-12
Cause 28:1331 Federal Question Assigned To Gary Scott Feinerman
Jury Demand None Referred To
Parties CADENCE PHARMACEUTICALS, INC.; FRESENIUS KABI USA, LLC; SCR PHARMATOP
Patents 6,028,222; 6,992,218
Attorneys Adam T Waskowski; Andrew Dylan Campbell; Kenneth G. Schuler; Marc N. Zubick; Stephen R. Buckingham
Firms Latham & Watkins LLP; Latham and Watkins LLP; Lowenstein Sandler; Novack and MacEy, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Cadence Pharmaceuticals, Inc. v. Fresenius Kabi USA, LLC
The small molecule drug covered by the patents cited in this case is ➤ Try a Free Trial .

Details for Cadence Pharmaceuticals, Inc. v. Fresenius Kabi USA, LLC (N.D. Ill. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-01-18 1 United States Patent No. 6,028,222 and U.S. Patent No. 6,992,218 (collectively, the “Patents-in-Suit”). … THE PATENTS-IN-SUIT 10. United States Patent No. 6,028,222 (“the ’222 patent”), titled… the ’222 patent. 11. Pharmatop granted an exclusive license to the ’222 patent to Bristol-Myers…copy of the ’222 patent is attached as Exhibit A. 12. United States Patent No. 6,992,218 (“… the ’218 patent. 13. Pharmatop granted an exclusive license to the ’218 patent to BMS, with External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
McKesson
Citi
Federal Trade Commission
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.